Amiloidosis sistémica AA: un problema potencial de salud pública

Autores/as

Palabras clave:

Salud pública, inocuidad alimentaria, amiloidosis, inflamación crónica, insuficiencia renal

Resumen

El objetivo de esta revisión es informar a los profesionales en salud animal, sobre la amiloidosis sistémica AA, un problema potencial de salud pública poco conocido en México, que puede derivarse del consumo de productos animales. Es difícil de diagnosticar, pues los signos clínicos dependen del tipo y localización del amiloide; y su fase terminal corresponde con un cuadro de insuficiencia renal. Consiste en la acumulación de un material proteico extracelular que puede originarse a partir de alrededor de 37 proteínas normales en los humanos y más de 15 en otros mamíferos acuáticos y terrestres, y en aves. Posee una estructura fibrilar característica en disposición β plegada que le confiere gran resistencia a agentes fisicoquímicos, que hace difícil su eliminación de los alimentos. Algunas amiloidosis, como el Alzheimer en humanos y el trastorno de disfunción cognitiva en los perros, son localizadas, pero la amiloidosis AA es sistémica y existe evidencia natural y experimental de que puede transmitirse intra e inter-especie cuando hay ingreso por vía oral, intravenosa o intraperitoneal de material amiloide en un individuo con una enfermedad inflamatoria crónica pre-existente u otros factores de riesgo, como la obesidad, lo que la convierte en un potencial problema de salud pública.

Citas

ANDREI M, Wang JC. 2019. Cutaneous light chain amyloidosis with multiple myeloma: A concise review. Hematology/oncology and stem cell therapy.12(2):71–81. https://doi.org/10.1016/j.hemonc.2018.09.003

BENSON MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva M, Sekijima Y, Sipe JD, Westermark P. 2018. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid: the international journal of experimental and clinical investigation: the official journal of the International Society of Amyloidosis. 25(4):215–219. https://doi.org/10.1080/13506129.2018.1549825

BIANCO C, Sánchez-Cordón PJ, Verin R, Godinho A, Weyer U, Lesellier S, Spiropoulos J, Floyd T, Everest D, Núñez A. 2020. Investigation into the Pathology of Idiopathic Systemic Amyloidosis in Four Captive Badgers (Meles meles). Journal of comparative pathology.176:128–132. https://doi.org/10.1016/j.jcpa.2020.02.012

BLANCAS-MEJÍA LM, Ramirez-Alvarado M. 2013. Systemic amyloidoses. Annual review of biochemistry. 82:745–774. https://doi.org/10.1146/annurev-biochem-072611-130030

BLANCHARD JL, Baskin GB, Watson EA. 1986. Generalized amyloidosis in rhesus monkeys. Veterinary pathology. 23(4): 425–430.

https://doi.org/10.1177/030098588602300412

BLANK N, Hegenbart U, Lohse P, Beimler J, Röcken C, Ho AD, Lorenz HM, Schönland SO. 2015. Risk factors for AA amyloidosis in Germany. Amyloid. 22(1): 1–7.

https://doi.org/10.3109/13506129.2014.980942

BLANK N, Hegenbart U, Dietrich S, Brune M, Beimler J, Röcken C, Müller-Tidow C, Lorenz HM, Schönland SO. 2018. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis. Amyloid. 25(1):37–45. https://doi.org/10.1080/13506129.2018.1429391

BOBYLEV AG, Fadeev RS, Bobyleva LG, Kobyakova MI, Shlyapnikov YM, Popov DV, Vikhlyantsev IM. 2021. Amyloid Aggregates of Smooth-Muscle Titin Impair Cell Adhesion. International journal of molecular sciences. 22(9):4579.

https://doi.org/10.3390/ijms22094579

BREILLAT P, Pourcher V, Deshayes S, Buob D, Cez A, Michel P A, Boffa J J, Langlois V, Grateau G, Georgin-Lavialle S. 2021. AA Amyloidosis in the Course of HIV Infection: A Report of 19 Cases Including 4 New French Cases and a Comprehensive Review of Literature. Nephron. 145(6): 675–683. https://doi.org/10.1159/000516982

BRUNGER AF, Nienhuis H, Bijzet J, Hazenberg B. 2020. Causes of AA amyloidosis: a systematic review. Amyloid. 27(1): 1–12.

https://doi.org/10.1080/13506129.2019.1693359

CONASIDA (Consejo Nacional para la prevención y control del SIDA). 2021. Sistema de vigilancia epidemiológica de VIH. Informe histórico Día mundial VIH 2021.

https://www.gob.mx/cms/uploads/attachment/file/685220/VIH-Sida__D_a_Mundial_2021.pdf

COOPER C, Bilbao J E, Said S, Alkhateeb H, Bizet J, Elfar A, Davalos O, Meza AT, Hernandez G T. 2013. Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user. Journal of Nephropatholy. 2(3): 196–200.

https://doi.org/10.12860/JNP.2013.31

D'SOUZA A, Theis JD, Vrana JA, Dogan A. 2014. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid.21(2): 71–75.

https://doi.org/10.3109/13506129.2013.876984

EISENBERG D, Jucker M. 2012. The amyloid state of proteins in human diseases. Cell.148(6):1188–1203. https://doi.org/10.1016/j.cell.2012.02.022

ENCODAT (Encuesta Nacional de consumo de drogas, alcohol y tabaco). 2016. Encuesta nacional de consumo de drogas, alcohol y tabaco 2016-2017. Pp.1. https://www.gob.mx/cms/uploads/ATTACHMENT/file/234856/CONSUMO_DE_DROGAS.pdf

FLORES RODRÍGUEZ J, Rivera Franco MM, Apodaca Cruz Á, Saldaña Montaño MC, Urbalejo Ceniceros VI, Meneses García A, Herrera Gómez A, Perez Camargo DA, Sevilla González ML. 2019. Incidence and characteristics of metabolic syndrome in patients of the National Cancer Institute of Mexico. Nutrición hospitalaria. 36 (6):1296–1299. https://dx.doi.org/10.20960/nh.02395

FLORES-TREVIÑO S, Rodríguez-Noriega E, Garza-González E, González-Díaz E, Esparza-Ahumada S, Escobedo-Sánchez R, Pérez-Gómez HR,León-Garnica G, Morfín-Otero R. 2019. Clinical predictors of drug-resistant tuberculosis in Mexico. PLoS ONE 14(8): e0220946. https://doi.org/10.1371/journal.pone.0220946

FRAME NM, Gursky O. 2017. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks. Amyloid. 24(1): 13-14 https://doi.org/10.1080/13506129.2016.1270930

FRANKLIN AD, Schmidt-Küntzel A, Terio KA, Marker LL, Crosier AE. 2016. Serum Amyloid A Protein Concentration in Blood is Influenced by Genetic Differences in the Cheetah (Acinonyx jubatus). The Journal of heredity. 107(2): 115–121. https://doi.org/10.1093/jhered/esv089

GAFFNEY PM, Witte C, Clifford DL, Imai DM, O'Brien TD, Trejo M, Liberta F, Annamalai K, Fändrich M, Masliah E, Munson L, Sigurdson CJ. 2016. Systemic Amyloid A Amyloidosis in Island Foxes (Urocyon littoralis): Severity and Risk Factors. Veterinary pathology. 53(3):637–647. https://doi.org/10.1177/0300985815604725

GALINDO SRM, Peniche OG, Herrera RJ, Gryzbowski E. 2013. Estimación de la prevalencia de artritis reumatoide en México. Value in health. ISPOR 16TH Annual European Congress Research abstracts. 16 (7): A719.

https://doi.org/10.1016/j.jval.2013.08.2235

GURSKY O. 2020. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve. Current atherosclerosis reports. 22(11): 69. https://doi.org/10.1007/s11883-020-00888-y

GREUNZ EM, Lemberger K, Catinaud J, Chenet B, Linke RP, Bräsen JH, Schmitz J, Bertelsen MF. 2020. AMYLOIDOSIS IN CARACALS (CARACAL CARACAL). Journal of zoo and wildlife medicine. 51(1):202–209. https://doi.org/10.1638/2019-0005

GRUYS E. 2004. Protein folding pathology in domestic animals. Journal of Zhejiang University-Science. 5(10):1226–1238. https://doi.org/10.1631/jzus.2004.1226

HAMPEL MR, Kinne J, Wernery U, Pospischil A, Kellermann J, Linke RP. 2009. Increasing fatal AA amyloidosis in hunting falcons and how to identify the risk: a report from the United Arab Emirates. Amyloid.16(3):122–132.

https://doi.org/10.1080/13506120903090759

HASHIMOTO M, Rockenstein E, Crews L, Masliah E. 2003. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromolecular medicine. 4:21–35. https://doi.org/10.1385/NMM:4:1-2:21

HUKKANEN RR, Liggitt HD, Anderson DM, Kelley ST 2006. Detection of systemic amyloidosis in the pig-tailed macaque (Macaca nemestrina). Comparative medicine. 56(2): 119–127. https://pubmed.ncbi.nlm.nih.gov/16639979/

INEGI (Instituto Nacional de Estadística, Geografía e Informática). 2020. Comunicado de prensa número 24/21. 25 de enero de 2021. Pp. 2.

https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/ResultCenso2020_Nal.pdf

JANSSON DS, Bröjer C, Neimanis A, Mörner T, Murphy,CL, Otman F, Westermark P. 2018. Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus). PloS ONE.13(3): e0193265.

https://doi.org/10.1371/journal.pone.0193265

JUCKER M, Walker LC. 2013. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature: 501(7465):45–51.

https://doi.org/10.1038/nature12481

JUNG O, Haack HS, Buettner M, Betz C, Stephan C, Gruetzmacher P, Amann K, Bickel M. 2012. Renal AA-amyloidosis in intravenous drug users--a role for HIV-infection?. BMC nephrology.13: 151. https://doi.org/10.1186/1471-2369-13-151

KADOTA A, Iwaide S, Miyazaki S, Mitsui I, Machida N, Murakami T. 2020. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.Veterinary pathology. 57(5): 658–665. https://doi.org/10.1177/0300985820934113

KHELLAF G, Benziane A, Kaci L, Benabadji M. 2022. AA renal amyloidosis: Clinical observations over 20 years. Clinical nephrology. 97:167-172.

https://doi.org/10.5414/CN110577

KLEIN A, Radespiel U, Felmy F, Brezina T, Ciurkiewicz M, Schmitz J, Bräsen JH, Linke R, P, Reinartz S, Distl O, Beineke A. 2021. AA-amyloidosis in captive northern tree shrews (Tupaia belangeri). Veterinary pathology. https://doi.org/10.1177/03009858211066847

LACHMANN HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. 2007. Natural history and outcome in systemic AA amyloidosis.The New England journal of medicine. 356(23): 2361–2371.

https://doi.org/10.1056/NEJMoa070265

LARSEN CP, Beggs ML, Wilson JD, Lathrop SL. 2016. Prevalence and organ distribution of leukocyte chemotactic factor 2 amyloidosis (ALECT2) among decedents in New Mexico.Amyloid.23(2): 119–123. https://doi.org/10.3109/13506129.2016.1145110

LEUNG ET, Raboin MJ, McKelvey J, Graham A, Lewis A, Prongay K, Cohen AM, Vinson A. 2019. Modelling disease risk for amyloid A (AA) amyloidosis in non-human primates using machine learning. Amyloid. 26(3): 139–147.

https://doi.org/10.1080/13506129.2019.1625038

LIN X, Watanabe K, Kuragano M, Tokuraku K. 2021. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A. International journal of molecular sciences. 22(3):1036. https://doi.org/10.3390/ijms22031036

LUDLAGE E, Murphy CL, Davern SM, Solomon A, Weiss DT, Glenn-Smith D, Dworkin S, Mansfield KG. 2005. Systemic AA amyloidosis in the common marmoset.Veterinary pathology. 42(2):117–124. https://doi.org/10.1354/vp.42-2-117

LUNDMARK K, Westermark G T, Olsén A, Westermark P. 2005. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.Proceedings of the National Academy of Sciences of the United States of America.102 (17): 6098–6102. https://doi.org/10.1073/pnas.0501814102

LUNDMARK K, Vahdat Shariatpanahi A, Westermark GT. 2013. Depletion of spleen macrophages delays AA amyloid development: a study performed in the rapid mouse model of AA amyloidosis. PloS ONE. 8(11):e79104.

https://doi.org/10.1371/journal.pone.0079104

MAJI SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KP, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W,Riek R. 2009. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science. 325(5938): 328–332. https://doi.org/10.1126/science.1173155

MARTIN DJ, Randles EG, Ramirez-Alvarado M. 2010. Fibril structure and fibrillogenesis. En: Gertz M.A. y Rajkumar S.J. Amyloidosis: Diagnosis and treatment 1ª edición. Humana Press. Pp.2. ISBN: 978-1-60761-631-3. https://doi.org/10.1007/978-1-60761-631-3

MARTINEZ ME, Zimmerman D, Seeley KE, Zhang L, Bapodra P, Cianciolo RE. 2019. Systemic amyloidosis in a population of pronghorn antelope (Antilocapra americana). Journal of zoo and wildlife medicine. 50(1):147–158.

https://doi.org/10.1638/2018-0055

MENDOZA JM, Peev V, Ponce MA, Thomas DB, Nayer A. 2013. Amyloid A amyloidosis with subcutaneous drug abuse. Journal of renal injury prevention. 3(1): 11–16. https://doi.org/10.12861/jrip.2014.06

MOLLEE P, Renaut P, Gottlieb D, Goodman H. 2014. How to diagnose amyloidosis. Internal medicine journal. 44(1): 7–17. https://doi.org/10.1111/imj.12288

MURAKAMI T, Inoshima Y, Watanabe K, Kobayashi Y, Matsui T, Kurazono H, Ishiguro N. 2011. Pathogenesis of experimental amyloid protein A amyloidosis in sore hocks-affected rabbits. Amyloid.18(3):112–118. https://doi.org/10.3109/13506129.2011.582901

MURAKAMI T, Muhammad N, Inoshima Y, Yanai T, Goryo M, Ishiguro N. 2013. Experimental induction and oral transmission of avian AA amyloidosis in vaccinated white hens. Amyloid. 20 (2): 80–85. https://doi.org/10.3109/13506129.2013.783474

MURAKAMI T, Ishiguro N, Higuchi K. 2014. Transmission of systemic AA amyloidosis in animals. Veterinary pathology. 51(2):363–371.

https://doi.org/10.1177/0300985813511128

MURAKAMI T, Inoshima Y, Ishiguro N. 2015. Systemic AA amyloidosis as a prion-like disorder.Virus research. 207: 76–81. https://doi.org/10.1016/j.virusres.2014.12.019

NAKAGUN S, Watanabe K, Matsuishi, T., Kobayashi, M., Kobayashi, Y. 2019. Surveillance of amyloidosis in stranded and bycaught cetaceans off Hokkaido, Japan. The Journal of veterinary medical science. 81(6): 897–902. https://doi.org/10.1292/jvms.18-0706

NAKAGUN S, Watanabe K, Tajima Y, Yamada TK, Kobayashi Y. 2020. Systemic Amyloid A Amyloidosis in Stejneger's Beaked Whales (Mesoplodon stejnegeri).Veterinary pathology. 57 (3):437–444. https://doi.org/10.1177/0300985820914079

NAKANO Y, Madarame H. 2020. Systemic amyloid A (AA) amyloidosis in the Bengalese finch (Lonchura striata var. domestica).The Journal of veterinary medical science. 82 (10): 1484–1487. https://doi.org/10.1292/jvms.20-0365

NIEWOLD TA, Murphy CL, Toussaint MJ, Solomon A, Gruys E. 2005. Chemical typing of porcine systemic amyloid as AA-amyloid. Amyloid.12(3): 164–166.

https://doi.org/10.1080/13506120500231806

OGAWA M, Shintani-Domoto Y, Nagashima Y, Ode KL, Sato A, Shimizu Y, Ohashi K, Roehrl M, Ushiku T, Ueda HR, Fukayama M. 2020. Mass spectrometry-based absolute quantification of amyloid proteins in pathology tissue specimens: Merits and limitations.PloS ONE.15 (7): e0235143.https://doi.org/10.1371/journal.pone.0235143

OLSSON M, Tintle L, Kierczak M, Perloski M, Tonomura N, Lundquist A, Murén E, Fels M, Tengvall K, Pielberg G, Dufaure de Citres C, Dorso L, Abadie J, Hanson J, Thomas A, Leegwater P, Hedhammar Å, Lindblad-Toh K, Meadows J. R. 2013. Thorough investigation of a canine autoinflammatory disease (AID) confirms one main risk locus and suggests a modifier locus for amyloidosis. PloS ONE. 8(10): e75242.

https://doi.org/10.1371/journal.pone.0075242

OVELGÖNNE JH, Landman WJ, Gruys E, Gielkens AL, Peeters BP. 2001. Identical amyloid precursor proteins in two breeds of chickens which differ in susceptibility to develop amyloid arthropathy. Amyloid. 8 (1): 41–51.

https://doi.org/10.3109/13506120108993813

PALTRINIERI S, Sironi G, Giori L, Faverzani S, Longeri M. 2015. Changes in serum and urine SAA concentrations and qualitative and quantitative proteinuria in Abyssinian cats with familial amyloidosis: a five-year longitudinal study (2009-2014). Journal of veterinary internal medicine. 29(2): 505–512. https://doi.org/10.1111/jvim.12561

PAPENDICK RE, Munson L, O'Brien TD, Johnson KH.1997. Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Veterinary pathology. 34(6): 549–556.

https://doi.org/10.1177/030098589703400602

PICKEN MM. 2020. The Pathology of Amyloidosis in Classification: A Review. Acta haematologica.143 (4): 322–334. https://doi.org/10.1159/000506696

REAL DE ASÚA D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos, J. 2014. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clinical epidemiology. 6: 369–377. https://doi.org/10.2147/CLEP.S39981

RICE KA, Chen ES, Metcalf Pate KA, Hutchinson EK, Adams RJ. 2013. Diagnosis of amyloidosis and differentiation from chronic, idiopathic enterocolitis in rhesus (Macaca mulatta) and pig-tailed (M. nemestrina) macaques. Comparative medicine. 63(3): 262–271.https://pubmed.ncbi.nlm.nih.gov/23759529/

RISING A, Cederlund E, Palmberg C, Uhlhorn H, Gaunitz S, Nordling K, Ågren E, Ihse E, Westermark GT, Tjernberg L, Jörnvall H, Johansson J, Westermark P. 2017. Systemic AA amyloidosis in the red fox (Vulpes vulpes). Protein science. 26(11): 2312–2318. https://doi.org/10.1002/pro.3264

RISING A, Gherardi P, Chen G, Johansson J, Oskarsson ME, Westermark GT, Westermark P. 2021. AA amyloid in human food chain is a possible biohazard. Scientific reports.11(1): 21069. https://doi.org/10.1038/s41598-021-00588-w

ROMANI M, Sorrentino V, Oh CM, Li H, de Lima TI, Zhang H, Shong M, Auwerx J. 2021. NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle. Cell reports. 34(3): 108660.

https://doi.org/10.1016/j.celrep.2020.108660

RUBEL MS, Fedotov SA, Grizel AV, Sopova JV, Malikova OA, Chernoff YO, Rubel AA. 2020. Functional Mammalian Amyloids and Amyloid-Like Proteins. Life. 10 (9):156.

https://doi.org/10.3390/life10090156

SACK GH., Jr 2018. Serum amyloid A - a review. Molecular medicine. 24 (1):46. https://doi.org/10.1186/s10020-018-0047-0

SCARPIONI R, Ricardi M, Albertazzi V. 2016. Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World journal of nephrology. 5 (1): 66–75. https://doi.org/10.5527/wjn.v5.i1.66

SEGEV G, Cowgill LD, Jessen S, Berkowitz A, Mohr CF, Aroch I. 2012. Renal amyloidosis in dogs: a retrospective study of 91 cases with comparison of the disease between Shar-Pei and non-Shar-Pei dogs. Journal of veterinary internal medicine. 26(2): 259–268. https://doi.org/10.1111/j.1939-1676.2011.00878.x

SIKORA J, Kmochová T, Mušálková D, Pohludka M, Přikryl P, Hartmannová H, Hodaňová K, Trešlová H, Nosková L, Mrázová L, Stránecký V, Lunová M, Jirsa M, Honsová E, Dasari S, McPhail ED, Leung N, Živná M, Bleyer A J, Rychlík I, Kmoch S. 2021. A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis. Kidney international. 101(2): 349-359. https://doi.org/10.1016/j.kint.2021.09.007

SILVA-HERNÁNDEZ L, Horga Hernández A, Valls Carbó A, Guerrero Sola A, Montalvo-Moraleda MT, Galán Dávila L. 2020. «Red flags» en pacientes con polineuropatía amiloidótica familiar relacionada con transtiretina (hATTR) en el momento del diagnóstico en un área no endémica de España. Neurología. S0213-4853 (20): 30212-7.

https://doi.org/10.1016/j.nrl.2020.06.009

SIPE JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Nomenclature Committee of the International Society of Amyloidosis .2012. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid.19(4): 167–170.

https://doi.org/10.3109/13506129.2012.734345

SIPE JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJ, Westermark P. 2016. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid.23(4): 209–213. https://doi.org/10.1080/13506129.2016.1257986

SØRBY R, Espenes A, Landsverk T, Westermark G. 2008. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Amyloid.15(1): 20–28. https://doi.org/10.1080/13506120701815332

TAMURA Y, Chambers JK, Neo S, Goto-Koshino Y, Takagi S, Uneyama M, Uchida, K, Hisasue M. 2020. Primary duodenal plasmacytoma with associated primary (amyloid light-chain) amyloidosis in a cat. Journal of Feline Medicine and Surgery open reports.6(2): 2055116920957194. https://doi.org/10.1177/2055116920957194

TANAKA S, Dan C, Kawano H, Omoto M, Ishihara T. 2008. Pathological study on amyloidosis in Cygnus olor (mute swan) and other waterfowl. Medical molecular morphology. 41(2): 99–108. https://doi.org/10.1007/s00795-008-0401-3

TOJO K, Tokuda T, Hoshii Y, Fu X, Higuchi K, Matsui T, Kametani F, Ikeda S. 2005. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid.12(2): 103–108. https://doi.org/10.1080/13506120500107097

VAN DER HEIJDEN RA, Bijzet J, Meijers WC, Yakala GK, Kleemann R, Nguyen TQ, de Boer RA, Schalkwijk CG, Hazenberg BP, Tietge UJ, Heeringa P. 2015. Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Scientific reports. 5: 16474.

https://doi.org/10.1038/srep16474

VAN DER HILST JC. 2011. Recent insights into the pathogenesis of type AA amyloidosis. The Scientific World Journal. 11: 641–650.

https://doi.org/10.1100/tsw.2011.64

VAN DER LINDE-SIPMAN JS, Niewold TA, Tooten PC, de Neijs-Backer M, Gruys E.1997. Generalized AA-amyloidosis in Siamese and Oriental cats. Veterinary immunology and immunopathology. 56 (1-2): 1–10. https://doi.org/10.1016/S0165-2427(96)05717-0

VAHDAT SHARIAT PANAHI A, Hultman P, Öllinger K, Westermark GT, Lundmark K. 2019. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis. Amyloid. 26(1): 34–44. https://doi.org/10.1080/13506129.2019.1576606

WEKELL P, Karlsson A, Fasth A, Berg S. 2016. Familjär medelhavsfeber - viktig sjukdom i en globaliserad värld - Särskilt vanlig hos personer från östra Medelhavsområdet [Familial Mediterranean fever – an important disease in a globalised world]. Lakartidningen. 113: DZFY. https://pubmed.ncbi.nlm.nih.gov/27551868/

WESTERMARK P, Andersson A, Westermark GT. 2011. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiological reviews. 91(3):795–826.

https://doi.org/10.1152/physrev.00042.2009

WESTERMARK GT, Fändrich M, Lundmark K, Westermark P. 2018. Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission. Cold Spring Harbor perspectives in medicine. 8(1): a024323.

https://doi.org/10.1101/cshperspect.a024323

ZHANG B, Une Y, Fu X, Yan J, Ge F, Yao J, Sawashita J, Mori M, Tomozawa H, Kametani, F, Higuchi K. 2008. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proceedings of the National Academy of Sciences of the United States of America. 105(20): 7263–7268.

https://doi.org/10.1073/pnas.0800367105

Descargas

Publicado

2022-06-11

Número

Sección

Revisiones de Literatura